Advertisement
Advertisement
GENB
G
Generate Biomedicines, Inc. Common Stock
13.02
USDSponsored
+0.60
+4.83%
May 20, 16:00 UTC -4
Closed
Pre-Market
13.93
+0.91
+6.99%
GENB Earnings Reports
Positive Surprise Ratio
GENB beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Generate Biomedicines, Inc. Common Stock earnings per share and revenue
On May 07, 2026, GENB reported earnings of -1.06 USD per share (EPS) for Q1 26, missing the estimate of -0.51 USD, resulting in a -107.84% surprise. Revenue reached 7.22 million, compared to an expected 6.06 million, with a 19.28% difference. The market reacted with a -11.21% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Santacruz Silver Mining Ltd. Common Shares
Report Date
May 15, 2026 For Q1 26
Estimate
$0.42
Actual
$0.30
Surprise
-28.96%
SpyGlass Pharma, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.69
Surprise
-35.77%
Blue Moon Metals Inc. Common Shares
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.42
Surprise
+2179.21%
Z Squared Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
-$0.65
Surprise
-
Merlin, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.10
Actual
$2.50
Surprise
+2560.78%
Blaize Holdings, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.19
Surprise
+4.47%
NeOnc Technologies Holdings, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.35
Surprise
-55.97%
Forian Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.02
Actual
-$0.13
Surprise
-737.25%
Sol Strategies Inc. Common Shares
Report Date
May 15, 2026 For Q2 26
Estimate
-$0.21
Actual
-$0.57
Surprise
-170.77%
York Space Systems Inc.
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.78
Surprise
-595.81%
FAQ
What were Generate Biomedicines, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Generate Biomedicines, Inc. Common Stock reported EPS of -$1.06, missing estimates by -107.84%, and revenue of $7.22M, 19.28% above expectations.
How did the market react to Generate Biomedicines, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -11.21%, changed from $15.30 before the earnings release to $13.59 the day after.
When is Generate Biomedicines, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Generate Biomedicines, Inc. Common Stock's next earnings report?
Based on --
analysts, Generate Biomedicines, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement